Biggest AMEX Stock Gainers Today were ILMN, PLX, AMLN : by Penny Stock Pick Alert
Penny Stock Pick Alert reports that Illumina, Inc., Amylin Pharmaceuticals, Inc. and Protalix BioTherapeutics Inc. today were Biggest AMEX Stock Gainers.
(EMAILWIRE.COM, November 25, 2009 ) Dallas, TX - Illumina, Inc. (NASDAQ:ILMN) climbed 5.62% to $27.99. The stock hit an intraday high and an intraday low of $28.15 and $26.20 respectively. In the last six months the stock went down over 21%. Illumina, Inc. is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function.
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) climbed 6.17% to $13.24 after Barclays Capital said it sees several catalysts warranting an upgrade of Amylin Pharmaceuticals Inc. to overweight from equalweight, including recent progress with diabetes drug Byetta and obesity products. The firm also sees a $2.5 billion opportunity from exenatide LAR from patients previously initiating Byetta and believes regulatory risk may be less than reflected in the current share price.
Protalix BioTherapeutics Inc. (AMEX:PLX) climbed 9.72% to $10.72. The stock hit an intraday high and an intraday low of $10.72 and $9.69 respectively. In the last six months the stock went up over 192%. Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system.
ABOUT PennyStockPickAlert.com
Penny Stock Pick Alerts by PennyStockPickAlert.com. If you are planning to invest into Stock Market then you must subscribe to Free Stock Newsletter and Alerts. We are a leading stock web site that provides free stock alerts on hot penny stocks that are poised to make big gains. We also tracks small cap penny stocks that could be on the brink of a massive breakout
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) climbed 6.17% to $13.24 after Barclays Capital said it sees several catalysts warranting an upgrade of Amylin Pharmaceuticals Inc. to overweight from equalweight, including recent progress with diabetes drug Byetta and obesity products. The firm also sees a $2.5 billion opportunity from exenatide LAR from patients previously initiating Byetta and believes regulatory risk may be less than reflected in the current share price.
Protalix BioTherapeutics Inc. (AMEX:PLX) climbed 9.72% to $10.72. The stock hit an intraday high and an intraday low of $10.72 and $9.69 respectively. In the last six months the stock went up over 192%. Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system.
ABOUT PennyStockPickAlert.com
Penny Stock Pick Alerts by PennyStockPickAlert.com. If you are planning to invest into Stock Market then you must subscribe to Free Stock Newsletter and Alerts. We are a leading stock web site that provides free stock alerts on hot penny stocks that are poised to make big gains. We also tracks small cap penny stocks that could be on the brink of a massive breakout
|
How to buy Penny Stocks
Learn the Skills, Make the Trades, Earn a Fortune! 100% Free to try. Chartpoppers.com Stop Being Fooled By "Penny Stock Picks" Subscribe To The #1 Rated MicroCap Stock Newsletter. MicroCapster.com Analyst Penny Stock Picks Visit StockSource.us for explosive stock picks, free stock research and trading tools www.StockSource.us Your text Ads here! Ads are only $575 per month. Ads are placed same day. Contac Us Emailwire.com/contact.php |

